Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Short-term sleeping tablet. | Body-clock hormone for sleep timing and jet lag. |
| Body system | Mental Health | Mental Health |
| Drug class | Z-drugs | Melatonin and agonists |
| Supply | Controlled drug | Pharmacist or prescription |
| Main uses | Short-term insomnia | Insomnia in people over 55, Sleep problems in children with ADHD or autism, Jet lag, Delayed sleep phase |
| How it works | Helps you fall asleep by quietening the brain. | Tells your body clock it's night-time. |
| Starts working | About 30 minutes | — |
| Half-life | About 2.5 hours | About 1 hour (immediate release) |
| Typical adult dose | 5–10 mg immediately at bedtime (5 mg for women in the US, and for older people). | 2 mg modified-release 1–2 hours before bed. Jet lag: 0.5–5 mg at local bedtime for a few days. |
| Forms | Tablet, Modified-release tablet, Sublingual tablet | Modified-release tablet, Tablet, Oral solution, Gummies (supplement) |
| Common side effects | Drowsiness next day, Dizziness, Headache | Headache, Daytime sleepiness, Vivid dreams |
| Serious side effects | Sleep-walking, sleep-driving or sleep-eating, Falls, Dependence | Rare; overdose of gummies in children is increasingly reported |
| Don't take if | Severe breathing problems or sleep apnoea; Severe liver impairment; Myasthenia gravis; History of complex sleep behaviours (sleep-walking, sleep-driving) | — |
| Alcohol | Best avoided. Alcohol adds dangerously to drowsiness and complex sleep behaviours. | — |
| Pregnancy | Usually avoidedAvoid regular use late in pregnancy. | Use with cautionNot recommended; limited data. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | 1992 | 2007 |
| Brand names | United States: Ambien, Ambien CRUnited Kingdom: StilnoctIndia: Zolfresh, Nitrest | United States: Supplements (various)United Kingdom: Circadin, SlenytoIndia: Meloset |
| Legal status | United States: Schedule IV controlled substanceUnited Kingdom: Controlled drug (Schedule 4, Part 1)India: Schedule H1 (sales are recorded) | — |
| ATC code | N05CF02 | N05CH01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker